BR0011039A - Análogos de gaba substituìdos com 3-heteroarilalquila - Google Patents

Análogos de gaba substituìdos com 3-heteroarilalquila

Info

Publication number
BR0011039A
BR0011039A BR0011039-6A BR0011039A BR0011039A BR 0011039 A BR0011039 A BR 0011039A BR 0011039 A BR0011039 A BR 0011039A BR 0011039 A BR0011039 A BR 0011039A
Authority
BR
Brazil
Prior art keywords
compounds
heteroarylalkyl
disorders
gaba analogs
useful
Prior art date
Application number
BR0011039-6A
Other languages
English (en)
Inventor
Po-Wai Yuen
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0011039A publication Critical patent/BR0011039A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Patente de Invenção: "ANáLOGOS DE GABA SUBSTITUìDOS COM 3-HETEROARILALQUILA". Esta invenção é uma nova série de compostos que são úteis no tratamento de epilepsia, ataques de fraqueza, distúrbios neurodegenerativos, depressão, ansiedade, pânico, dor, distúrbios neuropatológicos, distúrbios gastrintestinais tal como síndrome da irritação intestinal (IBS), e inflamação, especialmente artrite. São incluídos uma composição farmacêutica que contém um composto da invenção, bem como métodos de preparação dos compostos e novos intermediários úteis na preparação dos produtos finais.
BR0011039-6A 1999-05-28 2000-04-28 Análogos de gaba substituìdos com 3-heteroarilalquila BR0011039A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13649199P 1999-05-28 1999-05-28
PCT/US2000/011397 WO2000073296A2 (en) 1999-05-28 2000-04-28 3-heteroarylalkyl substituted gaba analogs

Publications (1)

Publication Number Publication Date
BR0011039A true BR0011039A (pt) 2002-02-26

Family

ID=22473084

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0011039-6A BR0011039A (pt) 1999-05-28 2000-04-28 Análogos de gaba substituìdos com 3-heteroarilalquila

Country Status (12)

Country Link
EP (1) EP1185524B1 (pt)
JP (1) JP2003500486A (pt)
AT (1) ATE287880T1 (pt)
AU (1) AU4673200A (pt)
BR (1) BR0011039A (pt)
CA (1) CA2371089A1 (pt)
DE (1) DE60017730T2 (pt)
ES (1) ES2234599T3 (pt)
MX (1) MXPA01011059A (pt)
PT (1) PT1185524E (pt)
TR (1) TR200103399T2 (pt)
WO (1) WO2000073296A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1820502A1 (en) 2006-02-10 2007-08-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising azolylcarbinol compounds
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
EP2353591A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
EP2388005A1 (en) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
EP2415471A1 (en) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in opioid-induced hyperalgesia
EP2524694A1 (en) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in diabetes type-2 associated pain
JP2016540771A (ja) 2013-12-17 2016-12-28 ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ セロトニン−ノルアドレナリン再取り込み阻害薬（ｓｎｒｉ）およびシグマ受容体リガンドの組み合わせ
EP3082790A1 (en) 2013-12-17 2016-10-26 Laboratorios Del. Dr. Esteve, S.A. Gabapentinoids and sigma receptor ligands combinations
CN115466234B (zh) * 2022-10-25 2024-01-30 安徽华业香料股份有限公司 一种γ-庚内酯的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0446097A1 (fr) * 1990-02-26 1991-09-11 Jouveinal S.A. Ethylamines substituées, leur procédé de préparation, leur utilisation comme médicament et leurs intermédiaires de synthèse
FR2722192A1 (fr) * 1994-07-06 1996-01-12 Adir Nouveaux derives de l'acide 4-amino butyrique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JPH08119936A (ja) * 1994-10-18 1996-05-14 Fujisawa Pharmaceut Co Ltd 複素環式誘導体
US6455047B1 (en) * 1997-09-19 2002-09-24 Serex, Inc. Methods to improve immunogenicity of antigens and specificity of antibodies

Also Published As

Publication number Publication date
MXPA01011059A (es) 2002-06-04
ES2234599T3 (es) 2005-07-01
PT1185524E (pt) 2005-04-29
AU4673200A (en) 2000-12-18
DE60017730T2 (de) 2005-06-23
CA2371089A1 (en) 2000-12-07
TR200103399T2 (tr) 2002-04-22
EP1185524B1 (en) 2005-01-26
EP1185524A2 (en) 2002-03-13
WO2000073296A3 (en) 2001-07-19
DE60017730D1 (de) 2005-03-03
WO2000073296A2 (en) 2000-12-07
ATE287880T1 (de) 2005-02-15
JP2003500486A (ja) 2003-01-07

Similar Documents

Publication Publication Date Title
NZ503651A (en) Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
EA200301232A1 (ru) Новые соединения арилсульфонамида и их применение для лечения ожирения, диабета типа ii и нарушений центральной нервной системы
EA200200716A1 (ru) Арилконденсированные азаполициклические соединения
SE0301010D0 (sv) Novel compounds
HK1098125A1 (en) Indane acetic acid compounds
CY1109760T1 (el) Παραγωγα ινδολης-3-θειου
SE0301009D0 (sv) Novel compounds
EA200401526A1 (ru) Новые соединения и их применение
TW200519075A (en) Novel compounds
DE60229530D1 (de) Substituierte piperazine als modulatoren des melanocortinrezeptors
UA48939C2 (uk) Дизаміщені фуранони, способи їх одержання, фармацевтична композиція на їх основі, спосіб лікування запального захворювання, проміжні сполуки
PT1448564E (pt) Composto do tipo indolizina substituidos e metodos de utilizacao
EA200601239A1 (ru) Замещённые хинолиновые соединения
EA200200293A1 (ru) Бициклические аминокислоты в качестве фармацевтических агентов
SE0300119D0 (sv) Novel compounds
BR0207640A (pt) Composição farmacêutica oral de cefpodoxima proxetil
EA200101134A1 (ru) Одно- и двузамещенные 3-пропил-гамма-аминомасляные кислоты
EA200501868A1 (ru) ТРИЦИКЛИЧЕСКИЕ δ-ОПИОИДНЫЕ МОДУЛЯТОРЫ
EA200301095A1 (ru) Бифенилкарбоксамиды, снижающие уровень липидов
BR0011039A (pt) Análogos de gaba substituìdos com 3-heteroarilalquila
EA200500348A1 (ru) N-арилпиперидинзамещенные бифенилкарбоксамиды в качестве ингибиторов секреции аполипопротеина b
TR200503401T1 (tr) Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları
EA200501865A1 (ru) Аналоги тиовольфраматов и их применение
EA200700203A1 (ru) Фармацевтическая композиция, содержащая габапентин
WO2002036118A3 (en) Heterocyclic derivatives useful as pharmaceutical agents

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7O, 8O E 9O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009.